N- pyroglutamyl- epsilon- palmitoyllysyl(16)- glucose-dependent insulinotropic polypeptide
may prove useful in diabetes 2 therapy
Also Known As:
glucose-dependent insulinotropic polypeptide, N-pyroglutamyl-epsilon-palmitoyllysyl(16)-; pGluGIP(LysPAL(16))
Networked: 0
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results